In this regulatory inspection webinar attendees will learn the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters; as well as, educate the audience on the essential elements of a thorough response. Also attendees will learn the proper structure of the response to ensure the regulatory agency’s expectations are met and the submission process is properly understood.
Why You Should Attend:
Every GMP manufacturing facility will experience a regulatory inspection at some point. If the outcome of the inspection results in a 483 or a Warning Letter, the firm must respond to the agency in a timely and proper fashion in order to avoid additional regulatory action.
Attendees of this course will understand regulatory expectations for firms that have received a 483 or Warning Letters; as well as, the consequences of not providing a proper response. Attendees will learn how to correctly structure and submit the response to ensure the regulatory agency’s expectations are met and the submission process is properly executed.
Areas Covered in the Session :
Review regulatory policies and procedures in regard to FDA 483 observations or Warning Letters
Understand the importance of responding to the observations
Discuss timelines and potential regulatory outcomes of not submitting an appropriate response
Understand who is the audience
Understand what the regulatory agency is expecting in the response
Structure of the Response
Review the components necessary to develop a thorough response
Review response checklist
Discuss recent Regulatory observations and review associated responses
Response Submission and Post Response Outcomes
Discuss the process for submitting the response to the regulatory agency
Discuss when and how to provide follow-up updates to the regulatory agency post the initial response
Discuss post response outcomes
Who Should Attend:
Quality Assurance Departments
Regulatory Affairs Departments
Engineering Departments
Operations Departments